Pathovax receives IND clearance for phase I study of HPV16 RG1-VLP

March 30, 2023

Pathovax LLC is developing a universally preventative human papillomavirus (HPV)...

BioWorld Science Immune Vaccine FDA IND

Today's news in brief

BioWorld

BioWorld briefs for May 6, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for May 5, 2026

The epidermal growth factor receptor in the inactive (left) and active (right) form.

Cytospire raises £61M series A to target EGFR in solid tumors

BioWorld

Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...

Bio Korea 2026: US policy risks shift to execution framework

BioWorld

Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...

Latus Bio series A financing supports early-stage programs

BioWorld Science

Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...